机构地区:[1]Department of Radiology, Peking University Third Hospital, Beijing 100191, China [2]Department of Neurology, Affiliated Hospital, Taishan Medical College, Tai'an 271000, China [3]Department of Medical Radiation Physics and Diagnostics, Helmholtz Zentrum Miinchen, German Research Center for Environmental Health (GmbH), Neuherberg 85764, Germany
出 处:《Science China(Life Sciences)》2011年第3期235-239,共5页中国科学(生命科学英文版)
基 金:supported by the National Natural Science Foundation of China(Grant Nos. 30972811 and 81071148);Natural Science Foundation of Beijing(Grant No. 7093137)
摘 要:Delivering pharmacologic agents directly into the brain has been proposed as a means of bypassing the blood brain barrier.However,despite 16 years of research on a number of central nervous system disorders,an effective treatment using this strategy has only been observed in the brain tumor glioblastoma multiforme.Within this study we propose a novel system for delivering drugs into the brain named the simple diffusion (SDD) system.To validate this technique,rats were subjected to a single intracranial (at the caudate nucleus),or intraperitoneal injection,of the compound citicoline,followed two hours later by a permanent middle cerebral artery occlusion (pMCAO).Results showed that 12 h after pMCAO,with 0.0025 g kg-1 citicoline,an infarct volume 1/6 the size of the intraperitoneal group was achieved with a dose 1/800 of that required for the intraperitoneal group.These results suggest that given the appropriate injection point,through SDD a pharmacologically effective concentration of citicoline can be administered.Delivering pharmacologic agents directly into the brain has been proposed as a means of bypassing the blood brain barrier.However,despite 16 years of research on a number of central nervous system disorders,an effective treatment using this strategy has only been observed in the brain tumor glioblastoma multiforme.Within this study we propose a novel system for delivering drugs into the brain named the simple diffusion (SDD) system.To validate this technique,rats were subjected to a single intracranial (at the caudate nucleus),or intraperitoneal injection,of the compound citicoline,followed two hours later by a permanent middle cerebral artery occlusion (pMCAO).Results showed that 12 h after pMCAO,with 0.0025 g kg^-1 citicoline,an infarct volume 1/6 the size of the intraperitoneal group was achieved with a dose 1/800 of that required for the intraperitoneal group.These results suggest that given the appropriate injection point,through SDD a pharmacologically effective concentration of citicoline can be administered.
关 键 词:permanent middle cerebral artery occlusion animal model brain ischemic injury citicoline therapy MRI NEUROPROTECTION
分 类 号:Q255[生物学—细胞生物学] S858.23[农业科学—临床兽医学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...